How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share details on what we are learning from real-world data collection efforts and answer questions from the audience.
Speakers include:
- Michael R. Anderson, MD, MBA, FAAP, FCCM, FAARC, Senior Advisor at the HHS Office of the Assistant Secretary for Preparedness and Response in Washington, D.C., and a key leader on the federal COVID-19 monoclonal antibody therapeutics team
- Marcus Snow MD, Rheumatologist at Nebraska Medicine; Assistant Professor of Internal Medicine, University of Nebraska Medical Center; and Chair of ACR Committee on Rheumatologic Care
- Kwas Huston MD, Rheumatologist at Kansas City Physician Partners and Clinical Associate Professor of Medicine, University of Missouri Kansas City
- Alfred Kim MD, PhD, Assistant Professor, Division of Rheumatology, School of Medicine at Washington University in St. Louis
- Jean Liew, MD, MS, Assistant Professor, Rheumatology, Boston University School of Medicine
The webinar is scheduled for 7 pm Eastern/4 pm Pacific on Wednesday, August 4. Register Online for free access and to submit questions.
Update: if you missed this webinar, the recording is below: